TAS2R46
geneOn this page
Also known as T2R54
Summary
TAS2R46 (taste 2 receptor member 46, HGNC:18877) is a protein-coding gene on chromosome 12p13.2, encoding Taste receptor type 2 member 46 (P59540). Receptor that may play a role in the perception of bitterness and is gustducin-linked.
TAS2R46 belongs to the large TAS2R receptor family. TAS2Rs are expressed on the surface of taste receptor cells and mediate the perception of bitterness through a G protein-coupled second messenger pathway (Conte et al., 2002 [PubMed 12584440]). For further information on TAS2Rs, see MIM 604791.
Source: NCBI Gene 259292 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 1 total
- Druggable target: yes — 2 molecules with ChEMBL bioactivity
- MANE Select transcript:
NM_176887
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18877 |
| Approved symbol | TAS2R46 |
| Name | taste 2 receptor member 46 |
| Location | 12p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | T2R54 |
| Ensembl gene | ENSG00000226761 |
| Ensembl biotype | protein_coding |
| OMIM | 612774 |
| Entrez | 259292 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000533467
RefSeq mRNA: 1 — MANE Select: NM_176887
NM_176887
CCDS: CCDS53748
Canonical transcript exons
ENST00000533467 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002166585 | 11061365 | 11062294 |
Expression profiles
Bgee: expression breadth broad, 42 present calls, max score 74.80.
Top tissues by expression
73 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 74.80 | gold quality |
| adrenal tissue | UBERON:0018303 | 67.11 | gold quality |
| corpus callosum | UBERON:0002336 | 65.37 | gold quality |
| calcaneal tendon | UBERON:0003701 | 59.51 | gold quality |
| bone marrow cell | CL:0002092 | 57.83 | silver quality |
| tonsil | UBERON:0002372 | 51.17 | silver quality |
| colonic epithelium | UBERON:0000397 | 50.90 | silver quality |
| sural nerve | UBERON:0015488 | 49.89 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 49.47 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 48.36 | gold quality |
| stromal cell of endometrium | CL:0002255 | 42.39 | silver quality |
| muscle tissue | UBERON:0002385 | 42.07 | gold quality |
| ventricular zone | UBERON:0003053 | 40.81 | gold quality |
| right coronary artery | UBERON:0001625 | 40.60 | silver quality |
| leukocyte | CL:0000738 | 40.52 | gold quality |
| urinary bladder | UBERON:0001255 | 40.47 | silver quality |
| monocyte | CL:0000576 | 40.28 | gold quality |
| ganglionic eminence | UBERON:0004023 | 39.97 | gold quality |
| liver | UBERON:0002107 | 39.37 | gold quality |
| granulocyte | CL:0000094 | 38.15 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 36.95 | silver quality |
| lung | UBERON:0002048 | 36.63 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| right ovary | UBERON:0002118 | 36.17 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 35.98 | gold quality |
| blood | UBERON:0000178 | 35.31 | gold quality |
| adrenal gland | UBERON:0002369 | 34.40 | gold quality |
| primary visual cortex | UBERON:0002436 | 34.30 | gold quality |
| kidney | UBERON:0002113 | 33.56 | gold quality |
| stomach | UBERON:0000945 | 33.51 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 7)
- MSC express the bitter taste receptor, TAS2R46, a protein more typically localized to the taste bud. Expression was also confirmed in VSMCs. (PMID:23520545)
- Gastrointestinal cancer risk is not associated with any TAS2R46 genotypes since there were no significant differences in genotype frequencies between cancer patients and controls (PMID:28552880)
- TAS2R46G>A rs2708381 is not associated with recurrent pregnancy loss in Korean women. (PMID:30203366)
- Absinthin, an agonist of the bitter taste receptor hTAS2R46, uncovers an ER-to-mitochondria Ca(2+)-shuttling event. (PMID:31248983)
- Structural basis for strychnine activation of human bitter taste receptor TAS2R46. (PMID:36108005)
- Bitter Taste Receptor 46 (hTAS2R46) Protects Monocytes/Macrophages from Oxidative Stress. (PMID:39000432)
- Single-Nucleotide Polymorphisms of TAS2R46 Affect the Receptor Downstream Calcium Regulation in Histamine-Challenged Cells. (PMID:39056786)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Tas2r136 | ENSMUSG00000053217 |
| mus_musculus | Tas2r120 | ENSMUSG00000059382 |
| rattus_norvegicus | Tas2r120 | ENSRNOG00000021445 |
| rattus_norvegicus | Tas2r136 | ENSRNOG00000029561 |
Paralogs (23): TAS2R8 (ENSG00000121314), TAS2R10 (ENSG00000121318), TAS2R7 (ENSG00000121377), TAS2R9 (ENSG00000121381), TAS2R3 (ENSG00000127362), TAS2R4 (ENSG00000127364), TAS2R5 (ENSG00000127366), TAS2R16 (ENSG00000128519), TAS2R1 (ENSG00000169777), TAS2R60 (ENSG00000185899), TAS2R42 (ENSG00000186136), TAS2R19 (ENSG00000212124), TAS2R50 (ENSG00000212126), TAS2R14 (ENSG00000212127), TAS2R13 (ENSG00000212128), TAS2R41 (ENSG00000221855), TAS2R40 (ENSG00000221937), TAS2R39 (ENSG00000236398), TAS2R43 (ENSG00000255374), TAS2R20 (ENSG00000255837), TAS2R30 (ENSG00000256188), TAS2R31 (ENSG00000256436), TAS2R38 (ENSG00000257138)
Protein
Protein identifiers
Taste receptor type 2 member 46 — P59540 (reviewed: P59540)
Alternative names: Taste receptor type 2 member 54
All UniProt accessions (1): P59540
UniProt curated annotations — full annotation on UniProt →
Function. Receptor that may play a role in the perception of bitterness and is gustducin-linked. May play a role in sensing the chemical composition of the gastrointestinal content. The activity of this receptor may stimulate alpha gustducin, mediate PLC-beta-2 activation and lead to the gating of TRPM5. In airway epithelial cells, binding of bitter compounds increases the intracellular calcium ion concentration and stimulates ciliary beat frequency.
Subcellular location. Membrane. Cell projection. Cilium membrane.
Tissue specificity. Expressed in subsets of taste receptor cells of the tongue and exclusively in gustducin-positive cells. Expressed on ciliated airway epithelium.
Miscellaneous. Most taste cells may be activated by a limited number of bitter compounds; individual taste cells can discriminate among bitter stimuli.
Similarity. Belongs to the G-protein coupled receptor T2R family.
RefSeq proteins (1): NP_795368* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007960 | TAS2R | Family |
Pfam: PF05296
UniProt features (35 total): helix 11, topological domain 8, transmembrane region 7, turn 3, glycosylation site 2, chain 1, sequence variant 1, sequence conflict 1, strand 1
Structure
Experimental structures (PDB)
8 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9W0R | ELECTRON MICROSCOPY | 2.7 |
| 9W0U | ELECTRON MICROSCOPY | 2.9 |
| 7XP4 | ELECTRON MICROSCOPY | 3.01 |
| 7XP6 | ELECTRON MICROSCOPY | 3.01 |
| 7XP5 | ELECTRON MICROSCOPY | 3.08 |
| 9W0W | ELECTRON MICROSCOPY | 3.2 |
| 9W0S | ELECTRON MICROSCOPY | 3.3 |
| 9W0T | ELECTRON MICROSCOPY | 3.3 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P59540-F1 | 86.06 | 0.43 |
Antibody-complex structures (SAbDab): 3 — 7XP4, 7XP5, 7XP6
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (2): 161, 176
Function
Pathways and Gene Ontology
Reactome pathways
9 pathways
| ID | Pathway |
|---|---|
| R-HSA-418594 | G alpha (i) signalling events |
| R-HSA-420499 | Class C/3 (Metabotropic glutamate/pheromone receptors) |
| R-HSA-9717207 | Sensory perception of sweet, bitter, and umami (glutamate) taste |
| R-HSA-162582 | Signal Transduction |
| R-HSA-372790 | Signaling by GPCR |
| R-HSA-388396 | GPCR downstream signalling |
| R-HSA-500792 | GPCR ligand binding |
| R-HSA-9709957 | Sensory Perception |
| R-HSA-9717189 | Sensory perception of taste |
MSigDB gene sets: 32 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE, GOBP_SENSORY_PERCEPTION_OF_TASTE, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, GOCC_CELL_PROJECTION_MEMBRANE, GOCC_PLASMA_MEMBRANE_REGION, GOCC_CILIARY_MEMBRANE, GOCC_CILIUM, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY, GOMF_TASTE_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of taste (GO:0050909)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), bitter taste receptor activity (GO:0033038)
GO Cellular Component (5): plasma membrane (GO:0005886), membrane (GO:0016020), ciliary membrane (GO:0060170), cilium (GO:0005929), cell projection (GO:0042995)
Reactome top-level categories
Rollup of top-6 pathways:
| Category | Pathways |
|---|---|
| Signaling by GPCR | 2 |
| GPCR downstream signalling | 1 |
| GPCR ligand binding | 1 |
| Sensory perception of taste | 1 |
| Signal Transduction | 1 |
| Sensory Perception | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| detection of chemical stimulus involved in sensory perception of taste | 1 |
| sensory perception of bitter taste | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| transmembrane signaling receptor activity | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of bitter taste | 1 |
| taste receptor activity | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cilium | 1 |
| cell projection membrane | 1 |
| bounding membrane of organelle | 1 |
| intraciliary transport particle | 1 |
| membrane-bounded organelle | 1 |
| plasma membrane bounded cell projection | 1 |
Protein interactions and networks
STRING
326 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TAS2R46 | GNAT3 | A8MTJ3 | 907 |
| TAS2R46 | PLCB2 | Q00722 | 898 |
| TAS2R46 | TAS1R2 | Q8TE23 | 606 |
| TAS2R46 | TAS1R1 | Q7RTX1 | 574 |
| TAS2R46 | PKD2L1 | Q9P0L9 | 521 |
| TAS2R46 | ZNF799 | Q96GE5 | 479 |
| TAS2R46 | PKD1L3 | Q7Z443 | 456 |
| TAS2R46 | TRPM5 | Q9NZQ8 | 438 |
| TAS2R46 | TAS1R3 | Q7RTX0 | 431 |
| TAS2R46 | OR6C1 | Q96RD1 | 416 |
| TAS2R46 | OR4C16 | Q8NGL9 | 408 |
| TAS2R46 | OR5M3 | Q8NGP4 | 390 |
| TAS2R46 | HCN4 | Q9Y3Q4 | 387 |
| TAS2R46 | FAM170B | A6NMN3 | 370 |
| TAS2R46 | TAS2R4 | Q9NYW5 | 363 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: P0DSN6, P0DTE0, P59537, P59538, P59539, P59540, P59541, P59542, P59543, P59544, Q5Y4Y8, Q5Y4Y9, Q5Y4Z5, Q5Y4Z8, Q5Y500, Q645T2, Q645T3, Q645T4, Q645T6, Q645V2, Q645V3, Q645V4, Q645V6, Q645V7, Q645Z2, Q645Z6, Q645Z7, Q645Z9, Q646A0, Q646A1, Q646B4, Q646B9, Q646C0, Q646C1, Q646C2, Q646C3, Q646E0, Q646E1, Q646E2, Q646E3
Diamond homologs: P0DSN6, P0DTE0, P59528, P59530, P59537, P59538, P59539, P59540, P59541, P59542, P59543, P59544, Q5Y4Y8, Q5Y4Y9, Q5Y4Z5, Q5Y4Z8, Q5Y500, Q645T0, Q645T2, Q645T3, Q645T4, Q645T6, Q645T7, Q645U8, Q645V1, Q645V2, Q645V3, Q645V4, Q645V6, Q645V7, Q645V8, Q645V9, Q645Z2, Q645Z5, Q645Z6, Q645Z7, Q645Z9, Q646A0, Q646A1, Q646A2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 1 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
332 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:11061900:A:AC | donor_gain | 0.7500 |
| 12:11061418:C:CC | acceptor_gain | 0.7100 |
| 12:11061672:T:C | acceptor_gain | 0.7000 |
| 12:11061413:CAAAA:C | acceptor_gain | 0.6600 |
| 12:11061684:T:TC | acceptor_gain | 0.6400 |
| 12:11061671:C:CC | acceptor_gain | 0.6300 |
| 12:11061550:C:CC | acceptor_gain | 0.6100 |
| 12:11061672:T:TC | acceptor_gain | 0.6100 |
| 12:11061700:T:TC | acceptor_gain | 0.6100 |
| 12:11061921:A:C | donor_gain | 0.6100 |
| 12:11061925:T:A | donor_gain | 0.6100 |
| 12:11061929:C:CC | acceptor_gain | 0.6100 |
| 12:11062109:TAA:T | donor_gain | 0.6100 |
| 12:11062056:A:AC | donor_gain | 0.6000 |
| 12:11062057:C:CC | donor_gain | 0.6000 |
| 12:11061687:C:CT | acceptor_gain | 0.5900 |
| 12:11061559:T:TC | acceptor_gain | 0.5700 |
| 12:11061689:C:CT | acceptor_gain | 0.5700 |
| 12:11061705:A:T | acceptor_gain | 0.5700 |
| 12:11062058:TTCTA:T | donor_gain | 0.5700 |
| 12:11062059:TCTAT:T | donor_gain | 0.5700 |
| 12:11061555:A:C | acceptor_gain | 0.5600 |
| 12:11061680:A:C | acceptor_gain | 0.5600 |
| 12:11061849:A:C | acceptor_gain | 0.5600 |
| 12:11061668:CAT:C | acceptor_gain | 0.5500 |
| 12:11061682:G:C | acceptor_gain | 0.5500 |
| 12:11061857:C:CT | acceptor_gain | 0.5500 |
| 12:11061669:ATC:A | acceptor_loss | 0.5400 |
| 12:11061670:TCT:T | acceptor_loss | 0.5400 |
| 12:11062057:CTT:C | donor_gain | 0.5400 |
AlphaMissense
2038 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:11061986:G:C | S103R | 0.880 |
| 12:11061986:G:T | S103R | 0.880 |
| 12:11061988:T:G | S103R | 0.880 |
| 12:11061941:A:C | F118L | 0.861 |
| 12:11061941:A:T | F118L | 0.861 |
| 12:11061943:A:G | F118L | 0.861 |
| 12:11062010:G:C | S95R | 0.843 |
| 12:11062010:G:T | S95R | 0.843 |
| 12:11062012:T:G | S95R | 0.843 |
| 12:11061593:G:C | F234L | 0.834 |
| 12:11061593:G:T | F234L | 0.834 |
| 12:11061595:A:G | F234L | 0.834 |
| 12:11062217:G:C | F26L | 0.823 |
| 12:11062217:G:T | F26L | 0.823 |
| 12:11062219:A:G | F26L | 0.823 |
| 12:11062117:A:G | W60R | 0.822 |
| 12:11062117:A:T | W60R | 0.822 |
| 12:11061992:G:C | S101R | 0.815 |
| 12:11061992:G:T | S101R | 0.815 |
| 12:11061994:T:G | S101R | 0.815 |
| 12:11061956:G:C | F113L | 0.802 |
| 12:11061956:G:T | F113L | 0.802 |
| 12:11061958:A:G | F113L | 0.802 |
| 12:11062244:A:C | F17L | 0.772 |
| 12:11062244:A:T | F17L | 0.772 |
| 12:11062246:A:G | F17L | 0.772 |
| 12:11062223:A:C | N24K | 0.769 |
| 12:11062223:A:T | N24K | 0.769 |
| 12:11062006:A:G | W97R | 0.759 |
| 12:11062006:A:T | W97R | 0.759 |
dbSNP variants (sampled 300 via entrez): RS1001601109 (12:11061640 G>A,C,T), RS1001611851 (12:11063919 A>T), RS1001843224 (12:11063059 C>G,T), RS1001935966 (12:11062882 T>A), RS1003278837 (12:11062539 A>G), RS1004956487 (12:11062183 T>C), RS1004959373 (12:11061082 G>A,T), RS1005728733 (12:11064257 G>A), RS1006369114 (12:11060893 G>A), RS1007395972 (12:11063046 T>C), RS1008989995 (12:11062811 A>C), RS1009083273 (12:11062460 T>A,C), RS1009086984 (12:11061891 C>T), RS1009274633 (12:11062816 T>C), RS1010221329 (12:11063005 TA>T,TAA)
Disease associations
OMIM: gene MIM:612774 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002144_3 | Bitter taste perception | 3.000000e-08 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: yes
ChEMBL targets (1): CHEMBL4523253 (SINGLE PROTEIN)
Molecules with ChEMBL bioactivity
2 molecules (phase ≥1), by development phase (incl. off-target/promiscuous compounds). Patent mentions across the top 20 by phase: 73,457 (via chembl_molecule»patent_compound — counts attach to the compound, not the gene–compound relationship, so off-target/promiscuous molecules can dominate).
| Molecule | Name | Phase | Patents |
|---|---|---|---|
| CHEMBL434 | ISOPROTERENOL | 4 | 40,234 |
| CHEMBL52440 | DEXTROMETHORPHAN | 4 | 33,223 |
PharmGKB: 1 entry (VIP=true, CPIC=false)
GtoPdb / IUPHAR curated pharmacology
(IUPHAR/BPS Guide to Pharmacology — expert-curated)
Target class: gpcr — Taste 2 receptors
Most potent curated ligand interactions (12 total), top 12:
| Ligand | Action | Affinity | Parameter |
|---|---|---|---|
| lactucopicrin | Agonist | 6.46 | pEC50 |
| strychnine | Agonist | 6.37 | pEC50 |
| oligoporin D | Agonist | 5.82 | pEC50 |
| 3β-hydroxydihydrocostunolide | Antagonist | 5.33 | pIC50 |
| grosheimin | Agonist | 5.25 | pEC50 |
| absinthin | Agonist | 5.0 | pEC50 |
| bengalensol | Agonist | 4.92 | pEC50 |
| andrographolide | Agonist | 4.89 | pEC50 |
| amarogentin | Agonist | 4.17 | pEC50 |
| picrotoxinin | Agonist | 4.15 | pEC50 |
| denatonium | Agonist | 3.62 | pEC50 |
| colchicine | Agonist | 2.8 | pEC50 |
ChEMBL bioactivities
16 potent at pChembl≥5 of 35 total, top 16 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).
| pChembl | Type | Value | Unit | Molecule |
|---|---|---|---|---|
| 8.31 | EC50 | 4.9 | nM | ISOPROTERENOL |
| 6.16 | EC50 | 690 | nM | STRYCHNINE |
| 5.96 | EC50 | 1100 | nM | CHEMBL4535452 |
| 5.96 | EC50 | 1100 | nM | CHEMBL4446651 |
| 5.56 | EC50 | 2740 | nM | CHEMBL4582048 |
| 5.32 | IC50 | 4810 | nM | CHEMBL4440983 |
| 5.32 | IC50 | 4810 | nM | CHEMBL4582048 |
| 5.31 | IC50 | 4930 | nM | CHEMBL4440983 |
| 5.31 | IC50 | 4930 | nM | CHEMBL4582048 |
| 5.27 | EC50 | 5390 | nM | CHEMBL4582048 |
| 5.17 | IC50 | 6780 | nM | CHEMBL4440983 |
| 5.17 | IC50 | 6780 | nM | CHEMBL4582048 |
| 5.08 | EC50 | 8300 | nM | DIHYDRO COSTUNOLIDE |
| 5.08 | EC50 | 8300 | nM | CHEMBL4564347 |
| 5.07 | EC50 | 8600 | nM | COSTUNOLIDE |
| 5.07 | EC50 | 8600 | nM | CHEMBL4435198 |
CTD chemical–gene interactions
7 total (human), top 7 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| 2-methyl-4-isothiazolin-3-one | decreases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| MT19c compound | increases expression | 1 |
| Ethanol | affects cotreatment, increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Folic Acid | affects cotreatment, increases expression | 1 |
| Silicon Dioxide | decreases expression | 1 |
ChEMBL screening assays
101 unique, capped per target: 81 functional, 20 binding
Representative assays (with source publication via chembl_document):
| Assay ID | Type | Description | Source paper |
|---|---|---|---|
| CHEMBL4417681 | Functional | Activation of full-length human TAS2R46 expressed in HEK293T/Galpha16-gustducin 44 cells assessed as effect on calcium flux by measuring deltaF/F0 ratio at 100 mM by Fluo-4 dye based FLIPR assay | Methods to identify tas2r modulators |
| CHEMBL4624177 | Binding | Agonist activity at human TAS2R46 expressed in human BEAS2B cells assessed as antiinflammatory activity by measuring reduction in PMA-induced iNOS mRNA level at 10 uM incubated for 18 hrs by qRT-PCR analysis | Anti-inflammatory Activity of Absinthin and Derivatives in Human Bronchoepithelial Cells. — J Nat Prod |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Targeted by drugs: Andrographolide, Colchicine, Taurolithocholic Acid